BioMedSA Legislative Priorities
Federal Priorities 1.Improved transparency and accountability for timely CMS reviews (reimbursement) medical devices, lab diagnostics. 2.Mental health support for clinical care staff and patients after pandemic. 3.Preserve the current definition of “independent contractor” to enable bioscience companies to augment their staff with independent contractors in within their scope of business to meet the needs of … Read more